Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A HEALTH authority has refused to approve a drug which would improve eye sight for patients with diabetes facing blindness.
NICE (National Institute for Health and Clinical Excellence) turned down an appeal by four charities to fund Lucentis on the NHS, a drug administered by injection which can improve eyesight for patients suffering diabetes macular oedema. DMO is a serious eye condition which can lead to sight loss as a result of fluid leaking from the small blood vessels in the eye.
http://www.sussexexpress.co.uk/news...ck_refusal_for_eye_sight_saving_jab_1_3326373
NICE (National Institute for Health and Clinical Excellence) turned down an appeal by four charities to fund Lucentis on the NHS, a drug administered by injection which can improve eyesight for patients suffering diabetes macular oedema. DMO is a serious eye condition which can lead to sight loss as a result of fluid leaking from the small blood vessels in the eye.
http://www.sussexexpress.co.uk/news...ck_refusal_for_eye_sight_saving_jab_1_3326373